Science Explorer Back to mapMap
Discussion
Researcher · Sozialstiftung Bamberg · Germany

Ruth Seggewiß-Bernhardt

Ruth Seggewiß-Bernhardt publishes mostly in Oncology, Hematology and Immunology, on topics such as Acute Myeloid Leukemia Research, Immune Cell Function and Interaction and CAR-T cell therapy research.

ORCID 0000-0001-7488-4791 OpenAlex
World rank
#1,866,486
of 7,710,434 ranked researchers
Rank in Germany
#92,080
of 364,343
Works
43
Citations
1.6k
Citations per work
36.3
h-index
16
i10-index 19Top 33% in Oncology
Ruth Seggewiß-Bernhardt

What does Ruth Seggewiß-Bernhardt research?

Ruth Seggewiß-Bernhardt's work is mostly in Medicine (50%), Immunology and Microbiology (13%), Biochemistry, Genetics and Molecular Biology (10%).

Health Sciences: 22 works · 50.1% of their workMedicine: 22 works · 50.1% of their workOncology: 8 works · 18.3% of their workHematology: 7 works · 16.7% of their workPulmonary and Respiratory Medicine: 5 works · 11.1% of their workGenetics: 2 works · 4.0% of their workEverything else: 12 works · 27.7% of their workLife Sciences: 10 works · 22.2% of their workImmunology and Microbiology: 5 works · 12.7% of their workImmunology: 5 works · 12.7% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 9.5% of their workMolecular Biology: 4 works · 9.5% of their workTHEIR WORKRuthSeggewiß-Bernhardt43works
Life Sciences22%Health Sciences50%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2250.1%
  2. Everything else1227.7%
    1. Immunology and Microbiology512.7%
    2. Biochemistry, Genetics and Molecular Biology49.5%
  1. 1Oncology18% of their works
  2. 2Hematology17% of their works
  3. 3Immunology13% of their works
  4. 4Pulmonary and Respiratory Medicine11% of their works
  5. 5Molecular Biology10% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Ruth Seggewiß-Bernhardt's research?

The keywords of their largest research topics: Acute Myeloid Leukemia, AML, Natural Killer Cells, NK Cell Recognition, CAR T Cells, Chimeric Antigen Receptor, Diagnosis Criteria and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 16 words, with their numbers
  1. AML91 topic
  2. Acute Myeloid Leukemia91 topic
  3. NK Cell Recognition81 topic
  4. Natural Killer Cells81 topic
  5. CAR T Cells61 topic
  6. Chimeric Antigen Receptor61 topic
  7. Diagnosis Criteria51 topic
  8. Foxp351 topic
  9. Immune Checkpoint Blockade51 topic
  10. International Myeloma Working Group51 topic
  11. PD-1 and PD-L151 topic
  12. Signaling51 topic
  13. TGF-ß51 topic
  14. mTOR51 topic
  15. JAK2 Mutation41 topic
  16. Myelofibrosis41 topic

Where does Ruth Seggewiß-Bernhardt work?

Ruth Seggewiß-Bernhardt's main affiliation in the publication record is Sozialstiftung Bamberg, Germany.

How many publications and citations does Ruth Seggewiß-Bernhardt have?

OpenAlex counts 43 works and 1,563 citations for Ruth Seggewiß-Bernhardt, an h-index of 16, ranking #1,866,486 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ruth Seggewiß-Bernhardt. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.